Movement Alert｜Tempus AI Falls 5.17% in Regular Trading, Partnership Termination and Executive Share Reduction Continue to Weigh on Stock

Market Focus07-17 00:24

On July 17, Tempus AI fell 5.17% in regular trading, trading at $54.214/share, with turnover of $123 million. The stock extended its recent weakness as multiple negative catalysts continued to pressure sentiment.

On the news front, Biovica International AB previously announced the termination of its collaboration agreement with Tempus AI, explicitly stating that the partnership failed to result in product commercialization or generate any revenue. Additionally, CEO and Chairman Eric P. Lefkofsky sold approximately 126,250 shares of Class A common stock through Rule 10b5-1 automatic trading plans at prices ranging from $54.82 to $59.59 per share. Freedom Capital Markets recently initiated coverage with a Hold rating and a $59 target price, which the current stock price has fallen significantly below.

Tempus AI operates as a healthcare technology company leveraging artificial intelligence for precision medicine, connecting laboratory results with patient clinical data to make diagnostic testing more intelligent and personalized. The company is scheduled to report Q2 earnings on July 30.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1189181183?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-17 00:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189181183","market":"us","top_or_hot":-1,"title":"Movement Alert｜Tempus AI Falls 5.17% in Regular Trading, Partnership Termination and Executive Share Reduction Continue to Weigh on Stock","media":"Market Focus","content":"<p><p>On July 17, Tempus AI fell 5.17% in regular trading, trading at $54.214/share, with turnover of $123 million. The stock extended its recent weakness as multiple negative catalysts continued to pressure sentiment.</p><p>On the news front, Biovica International AB previously announced the termination of its collaboration agreement with Tempus AI, explicitly stating that the partnership failed to result in product commercialization or generate any revenue. Additionally, CEO and Chairman Eric P. Lefkofsky sold approximately 126,250 shares of Class A common stock through Rule 10b5-1 automatic trading plans at prices ranging from $54.82 to $59.59 per share. Freedom Capital Markets recently initiated coverage with a Hold rating and a $59 target price, which the current stock price has fallen significantly below.</p><p>Tempus AI operates as a healthcare technology company leveraging artificial intelligence for precision medicine, connecting laboratory results with patient clinical data to make diagnostic testing more intelligent and personalized. The company is scheduled to report Q2 earnings on July 30.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Tempus AI Falls 5.17% in Regular Trading, Partnership Termination and Executive Share Reduction Continue to Weigh on Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Tempus AI Falls 5.17% in Regular Trading, Partnership Termination and Executive Share Reduction Continue to Weigh on Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-17 00:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 17, Tempus AI fell 5.17% in regular trading, trading at $54.214/share, with turnover of $123 million. The stock extended its recent weakness as multiple negative catalysts continued to pressure sentiment.</p><p>On the news front, Biovica International AB previously announced the termination of its collaboration agreement with Tempus AI, explicitly stating that the partnership failed to result in product commercialization or generate any revenue. Additionally, CEO and Chairman Eric P. Lefkofsky sold approximately 126,250 shares of Class A common stock through Rule 10b5-1 automatic trading plans at prices ranging from $54.82 to $59.59 per share. Freedom Capital Markets recently initiated coverage with a Hold rating and a $59 target price, which the current stock price has fallen significantly below.</p><p>Tempus AI operates as a healthcare technology company leveraging artificial intelligence for precision medicine, connecting laboratory results with patient clinical data to make diagnostic testing more intelligent and personalized. The company is scheduled to report Q2 earnings on July 30.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TEM","symbol_name":"Tempus AI","start_time":0,"source_url":"","article_id":"1189181183","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189181183","pubTimestamp":1784219092,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 17, Tempus AI fell 5.17% in regular trading, trading at $54.214/share, with turnover of $123 million. The stock extended its recent weakness as multiple negative catalysts continued to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TEM":"Tempus AI"},"translate_title":"走势提醒|腾邦人工智能常规交易下跌5.17%，合作伙伴关系终止和高管减持继续拖累股价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TEM":1},"content_text":"On July 17, Tempus AI fell 5.17% in regular trading, trading at $54.214/share, with turnover of $123 million. The stock extended its recent weakness as multiple negative catalysts continued to pressure sentiment.On the news front, Biovica International AB previously announced the termination of its collaboration agreement with Tempus AI, explicitly stating that the partnership failed to result in product commercialization or generate any revenue. Additionally, CEO and Chairman Eric P. Lefkofsky sold approximately 126,250 shares of Class A common stock through Rule 10b5-1 automatic trading plans at prices ranging from $54.82 to $59.59 per share. Freedom Capital Markets recently initiated coverage with a Hold rating and a $59 target price, which the current stock price has fallen significantly below.Tempus AI operates as a healthcare technology company leveraging artificial intelligence for precision medicine, connecting laboratory results with patient clinical data to make diagnostic testing more intelligent and personalized. The company is scheduled to report Q2 earnings on July 30.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"executive,corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1189181183","isCrawlerRequest":true}